SEC Form 4 · accession 0001209191-18-061532
Cardlytics, Inc. · CDLX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Thomas Evans
Officer — Chief Financial Officer
Period of report
Dec 5, 2018
Accepted (ET)
Dec 7, 2018 · 4:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001666071
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Performance Stock UnitF1,F2 | — | Dec 5, 2018 | A | 75,000 | A | — | — | Common Stock | 75,000 | 75,000 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of share of the Issuer's Common Stock.
- F2The performance stock units ("PSUs") vested upon the Compensation Committee of the Issuer's Board of Directors certifying that at least 85,000,000 customers or accounts of the Issuer's financial institution ("FI") partners had logged in and visited the online or mobile banking applications of the Issuer's FI partners featuring the Issuer's Cardlytics Direct product, or opened an email from the Issuer's FI partners featuring the Issuer's Cardlytics Direct product, during a monthly period ("MAUs"). The PSUs have not yet settled.